Cartalax, 20mg

Cartalax belongs to the class of ultrashort peptides known to act as epigenetic modulators. By interacting with the nucleosomes of connective tissue cells, it is investigated for its ability to “reset” gene expression to a more youthful state.

Key Areas of Experimental Focus:

• Fibroblast Proliferation: Research indicates that Cartalax supports the growth and activity of fibroblasts—the primary cells responsible for producing the extracellular matrix (ECM) and collagen.

• Cytokine Modulation: Experimental models suggest that Cartalax may regulate the expression of specific cytokines and signaling molecules (such as MMP-9) linked to inflammation and the breakdown of tissue architecture.

• Anti-Senescence Properties: Studies have explored its role in reducing markers of cellular aging (senescence), such as p16 and p21, while potentially increasing longevity-associated proteins like SIRT1.

• Tissue-Specific Applications: Beyond cartilage and joints, findings suggest that Cartalax may promote cellular health in the kidneys and dermal layers, enhancing repair mechanisms and inhibiting caspase-dependent apoptosis (cell death).

Chemical & Technical Specifications